Targeted RFA 2019
Movember Translation Acceleration Grant to improve patient outcomes and treatment planning with advanced imaging
With this funding opportunity announcement, Prostate Cancer Canada (PCC) invites members of the prostate cancer research community to collaboratively participate in a multi-stage process to submit one (1) application for an investigator-initiated Translational Acceleration Grant (TAG).
New imaging modalities are increasing our ability to detect low volume prostate cancer metastases. The project funded by this mechanism will explore how advanced imaging such as PET, CT and mpMRI, together with appropriate treatment for men with advanced prostate cancer can lead to better outcomes.
A multidisciplinary approach is required and the Movember TAG application will consist of independent investigators based in multiple institutions.
PCC will only consider a project that is focused completely on prostate cancer.
This request for applications (RFA) is a multi-step process:
- Individuals submit an Expression of Interest to participate in developing a proposal. Selected individuals will be brought together with the intention of collaborating.
- As a team, submit an application that will have the greatest potential to demonstrate the value of incorporating advanced imaging modalities into prostate cancer management in Canada and abroad by designing and carrying out a prospective clinical trial that evaluates patient outcomes following image-guided treatment planning.
This opportunity is awarded by Prostate Cancer Canada and proudly funded by the Movember Foundation.
Award amount: up to $3M over 3 years
Key dates; note extended timeline:
Expression of Interest Letters from Individuals Deadline: June 27, 2019
Invitations extended to Individuals to attend Planning Meeting: July 12, 2019
Planning Meeting in Toronto: September 23, 2019
Team Registration Deadline:
November 27, 2019
Full Application Deadline:
January 29, 2020
Review Panel Meeting and Reverse Site Visit in Toronto:
TBD (late February - early March 2020)
Funding start date:
April 1, 2020
Links to:
Program Description
Frequently Asked Questions